The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Davidson, Michael H.
One or more keywords matched the following items that are connected to Davidson, Michael H.
Item TypeName
Concept Cholesterol Ester Transfer Proteins
Academic Article Effect of marine lipids on cholesteryl ester transfer and lipoprotein composition in patients with hypercholesterolemia.
Academic Article The safety and immunogenicity of a CETP vaccine in healthy adults.
Academic Article Therapeutic interventions targeted at the augmentation of reverse cholesterol transport.
Academic Article Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels on a background of atorvastatin.
Academic Article Biologic therapies for dyslipidemia.
Academic Article Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels.
Academic Article Low high-density lipoprotein cholesterol and increased cardiovascular disease risk: an analysis of statin clinical trials.
Academic Article Novel targets that affect high-density lipoprotein metabolism: the next frontier.
Academic Article Safety of anacetrapib in patients with or at high risk for coronary heart disease.
Academic Article Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib.
Academic Article Focus on HDL as a therapeutic target for CAD risk reduction.
Academic Article Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib.
Academic Article Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease?
Academic Article Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial.
Academic Article Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease.
Academic Article Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial.
Academic Article Comparison of low-density lipoprotein cholesterol equations in patients with dyslipidaemia receiving cholesterol ester transfer protein inhibition.
Academic Article Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments.
Search Criteria
  • Cholesterol Ester Transfer Proteins